Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance
Status: Recruiting
Location: See all (6) locations...
Intervention Type: Drug
Study Type: Observational
SUMMARY
The purpose of this surveillance is to assess the safety and efficacy of Poteligeo Inj. 20 mg (mogamulizumab) in routine clinical settings.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Healthy Volunteers: f
View:
• Adults 19 years of age or older
• Individuals who are confirmed to have received administration of the study drug for the purpose of the treatment for adult patients with fungoidal granuloma or Sezary syndrome who have received one or more systemic therapies, or who are considered to require administration of the study drug in the investigator's opinion
• Individuals who (or whose legally acceptable representatives) signed the Consent to Use of Personal Information of their own free will for participation in this use-result surveillance
Locations
Other Locations
Republic of Korea
Kosin University Gospel Hospital
RECRUITING
Busan
Chung-Ang University Hospital
TERMINATED
Seoul
Ewha Womans University Mokdong Hospital
RECRUITING
Seoul
Samsung Medical Center
RECRUITING
Seoul
Seoul National University Hospital
RECRUITING
Seoul
Seoul National University Hospital
RECRUITING
Seoul
Contact Information
Primary
HaeMi Park
haemi.park.m8@kyowakirin.com
+82-10-3378-3471
Time Frame
Start Date: 2025-05-02
Estimated Completion Date: 2028-11
Participants
Target number of participants: 15
Related Therapeutic Areas
Sponsors
Leads: Kyowa Kirin Co., Ltd.